2021
DOI: 10.1007/s11248-021-00274-7
|View full text |Cite
|
Sign up to set email alerts
|

Sustainable use of CRISPR/Cas in fish aquaculture: the biosafety perspective

Abstract: Aquaculture is becoming the primary source of seafood for human diets, and farmed fish aquaculture is one of its fastest growing sectors. The industry currently faces several challenges including infectious and parasitic diseases, reduced viability, fertility reduction, slow growth, escapee fish and environmental pollution. The commercialization of the growth-enhanced AquAdvantage salmon and the CRISPR/Cas9-developed tilapia (Oreochromis niloticus) proffers genetic engineering and genome editing tools, e.g. CR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
48
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 49 publications
(50 citation statements)
references
References 115 publications
(199 reference statements)
0
48
0
2
Order By: Relevance
“…The CRISPR/Cas9 genome editing technology holds a great promise for disease control and molecular breeding in aquaculture. Unlike traditional transgenesis, which involves the transfer of a gene from one organism to other concerning the public safety regulations of genetically modified organisms, CRISPR/Cas genome editing allows specific, targeted, and often minor changes to the genome of the species of interest, and it does not introduce any foreign DNA, thereby alleviating major public concerns on the safety of GMOs (Okoli et al, 2021). The provision of the in vitro synthesis of sgRNA allows for multiplex CRISPR/ Cas9 for editing at multiple sites on the targeted gene and also for the higher probability of a gene knockout event.…”
Section: Advances Of Crispr/cas-genome Editing In Aquaculture and Fis...mentioning
confidence: 99%
See 3 more Smart Citations
“…The CRISPR/Cas9 genome editing technology holds a great promise for disease control and molecular breeding in aquaculture. Unlike traditional transgenesis, which involves the transfer of a gene from one organism to other concerning the public safety regulations of genetically modified organisms, CRISPR/Cas genome editing allows specific, targeted, and often minor changes to the genome of the species of interest, and it does not introduce any foreign DNA, thereby alleviating major public concerns on the safety of GMOs (Okoli et al, 2021). The provision of the in vitro synthesis of sgRNA allows for multiplex CRISPR/ Cas9 for editing at multiple sites on the targeted gene and also for the higher probability of a gene knockout event.…”
Section: Advances Of Crispr/cas-genome Editing In Aquaculture and Fis...mentioning
confidence: 99%
“…To induce heritable modifications through gene editing, it must happen very early in the development, ideally at the onecell stage so that they can be incorporated in its germ line, hence the need for specialized methods like microinjection to deliver the CRISPR/Cas complex on a microscopic scale. Nevertheless, other procedures to deliver the CRISPR/Cas9 complex into one-cell fertilized eggs or cultured cell are lentivirus-mediated methods, electroporation, and ribonucleoprotein complexes (Okoli et al, 2021;Yang et al, 2022). Mutants should be carefully screened using sequence analysis, and off-target affects should be assessed.…”
Section: Advances Of Crispr/cas-genome Editing In Aquaculture and Fis...mentioning
confidence: 99%
See 2 more Smart Citations
“…Second, genetic containment can be accomplished with sterile fish that prevent polluting wild populations’ genetic pool when selectively bred or even genetically modified farmed fish escape. Especially, sterilization is vital for containing transgenics and genome-edited mutants for their commercial applications [ 184 , 185 ]. Third, sterility is a means for producers to protect valuable strains from unauthorized propagation and unexpected technological leakages.…”
Section: Advanced Applications Of Germ Cell Transplantationmentioning
confidence: 99%